Coronary interventions

Stents and scaffolds

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment.

Filters

Search by author

Filter by type

Showing 1-20 of 225 articles

Coronary interventions

Prevalence, Predictors, and Outcomes of In-Stent Restenosis With Calcified Nodules

Tada T, Miura K, Ohya M, Shimada T, Osakada K, Ikuta A, Takamatsu M, Taguchi Y, Kubo S, Tanaka H, Fuku Y, Kadota K

August 31, 2021 | 10.4244/EIJ-D-21-00504

Coronary interventions

Long-Term Clinical Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: Final 5-Year Results of the AIDA Randomized Clinical Trial

Kerkmeijer L, Renkens MP, Tijssen RY, Hofma S, van der Schaaf R, Arkenbout E, Weevers AP, Garcia-Garcia H, Kraak R, Piek J, Tijssen J, Henriques J, de Winter R, Wykrzykowska J

August 31, 2021 | 10.4244/EIJ-D-21-00419

Coronary interventions

Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study

Baber U, Sharma S, Giustino G, Sartori S, Nicolas J, Goel R, Mehta S, Cohen D, Angiolillo D, Zhang Z, Camaj A, Cao D, Briguori C, Dudek D, Escaned J, Huber K, Collier T, Kornowski R, Kunadian V, Moliterno DJ, Ohman EM, Weisz G, Gil R, Krucoff M, Kaul U, Oldroyd K, Sardella G, Shlofmitz R, Witzenbichler B, Kastrati A, Han Y, Steg P, Pocock S, Gibson CM, Mehran R

August 26, 2021 | 10.4244/EIJ-D-21-00721

Coronary interventions

Optimal Dual Antiplatelet Therapy Duration for Bioresorbable Scaffolds: an Individual Patient Data Pooled Analysis of the ABSORB Trials

Azzalini L, Ellis SG, Kereiakes D, Kimura T, Gao R, Onuma Y, Chevalier B, Dressler O, Crowley A, Zhou Z, Redfors B, Serruys P, Stone G

June 8, 2021 | 10.4244/EIJ-D-21-00263

Coronary interventions

Optical Flow Ratio for Assessing Stenting Result and Physiological Significance of Residual Disease

Ding D, Yu W, Tauzin H, De Maria G, Wu P, Yang F, Kotronias R, Terentes-Printzios D, Wolfrum M, Banning A, Meneveau N, Wijns W, Tu S

June 8, 2021 | 10.4244/EIJ-D-21-00185

Coronary interventions

Clopidogrel Monotherapy in Patients with and without On-Treatment High Platelet Reactivity: a SMART-CHOICE sub-study

Lee SH, Lee SY, Chun WJ, Song Y, Choi S, Jeong J, Oh SK, Yun K, Koh Y, Bae J-W, Choi JW, Gwon H, Hahn J

May 25, 2021 | 10.4244/EIJ-D-21-00223

Coronary interventions

Clinical Outcomes By Angiographic Type Of Spontaneous Coronary Artery Dissection

Mori R, Macaya F, Giacobbe F, Salinas P, Pavani M, Boi A, Bettari L, Rolfo C, Porto I, Gonzalo N, Varbella F, Cerrato E, Escaned J

March 2, 2021 | 10.4244/EIJ-D-20-01275

Coronary interventions

A randomized comparison of Coronary Stents according to Short or Prolonged durations of Dual Antiplatelet Therapy in patients with Acute Coronary Syndromes: a pre-specified analysis of the SMART-DATE trial

Jang WJ, Lee J, Song Y, Choi KH, Choi S, Chun WJ, Oh JH, Park I, Doh J, Jeong J, Park J, Gwon H, Hahn J

November 10, 2020 | 10.4244/EIJ-D-20-00556

Coronary interventions

Culprit lesion location and outcomes in patients with multi-vessel disease and infarct-related cardiogenic shock. A core laboratory analysis of the CULPRIT-SHOCK trial

Hauguel-Moreau M, Barthelemy O, Farhan S, Huber K, Rouanet S, Zeitouni M, Guedeney P, Hage G, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G

September 8, 2020 | 10.4244/EIJ-D-20-00561

Coronary interventions

Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis

Xhepa E, Bresha J, Joner M, Hapfelmeier A, Rivero F, Ndrepepa G, Nano N, Cuesta J, Kufner S, Cassese S, Bastante T, Aytekin A, Rroku A, Garcia Guimaraes M, Lahmann A, Pinieck S, Rai H, Fusaro M, Schunkert H, Perez Vizcayno MJ, Gonzalo N, Alfonso F, Kastrati A

September 8, 2020 | 10.4244/EIJ-D-20-00662

Coronary interventions

Long-Term Outcomes of In-Stent Restenosis Percutaneous Coronary Intervention among Medicare Beneficiaries

Tamez H, Secemsky E, Valsdottir L, Moussa I, Song Y, Simonton C, Gibson CM, Popma J, Yeh R

September 1, 2020 | 10.4244/EIJ-D-19-01031

Coronary interventions

Peri-procedural stent thrombosis following bifurcational PCI of lipid-rich plaque: serial optical coherence tomography insights

Häner J, Lanz J, Otsuka T, Räber L

August 18, 2020 | 10.4244/EIJ-D-20-00731

Coronary interventions

Dual antiplatelet therapy strategies and clinical outcomes in patients treated with polymer-free biolimus A9-coated stents

D'Ascenzo F, Gallone G, Boccuzzi G, Cortese B, Di Biasi M, Capodanno D, Vicinelli P, Infantino V, Poli A, Grigis G, Varbella F, De Ferrari G, Ielasi A

February 7, 2020 | 10.4244/EIJ-D-19-00450

Coronary interventions

Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial

Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek J, Wykrzykowska J, Asano T, Kogame N, Takahashi K, Chang C, de Winter R, Serruys P, Wijns W

February 7, 2020 | 10.4244/EIJ-D-18-00944

Coronary interventions

Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Haude M, Ince H, Toelg R, Lemos P, von Birgelen C, Christiansen E, Wijns W, Neumann F, Eeckhout E, Garcia-Garcia H, Waksman R

February 7, 2020 | 10.4244/EIJ-D-18-01000

Coronary interventions

Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry

Verheye S, Wlodarczak A, Montorsi P, Bennett J, Torzewski J, Haude M, Vrolix M, Buck T, Aminian A, van der Schaaf R, Nuruddin A, Lee M

February 7, 2020 | 10.4244/EIJ-D-18-01058

Coronary interventions

The obesity paradox revisited: body mass index and long-term outcomes after PCI from a large pooled patient-level database

Wolny R, Maehara A, Liu Y, Zhang Z, Mintz G, Redfors B, Madhavan M, Smits P, von Birgelen C, Serruys P, Mehran R, Leon M, Stone G

January 17, 2020 | 10.4244/EIJ-D-19-00467

Coronary interventions

First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent versus a durable fluoropolymer-based everolimus-eluting stent in patients with coronary artery disease: the ANGIOLITE trial

Moreu J, Moreno-Gómez R, Pérez de Prado A, García del Blanco B, Trillo R, Pinar E, Molina E, Zueco J, Merchán A, Díaz-Fernández J, Amat I

December 20, 2019 | 10.4244/EIJ-D-19-00206

Coronary interventions

Effect of rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: the LINK-IT Trial

Kuroda K, Otake H, Shinohara M, Kuroda M, Tsuda S, Toba T, Nagano Y, Toh R, Ishida T, Shinke T, Hirata K

December 20, 2019 | 10.4244/EIJ-D-18-01073

Coronary interventions

BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

December 6, 2019 | 10.4244/EIJ-D-18-01214

1
2
3
…
12

Valvular disease